Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial With Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine in Patients With Advanced Pancreatic Cancer

NCT00440167 is registered in ClinicalTrials.gov with PD Dr. med. Volker Heinemann as lead sponsor.

NCT NCT00440167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial With Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine in Patients With Advanced Pancreatic Cancer
Lead sponsor
PD Dr. med. Volker Heinemann
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2006
Completion date
December 31, 2012
Enrollment
280 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer